IRCT2016102730410N2已完成2 期
A novel protocol for anti coagulation therapy after coronary endarterectomy in coronary artery bypass graft patients
Babol University of Medical Sciences, Deputy of Research & Technology0 个研究点目标入组 55 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 55
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •inclusion criteria: patients undergoing Cronary artery bypass graft / coronary endarterectomy
- •Exclusion criteria were as follows : need to concomitant valve surgery ; history of allergic reaction to Asprin and Plavix; any systemic disease
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Development of antiplatelet therapy protocol for coil embolization of intracranial aneurysmDiseases of the nervous systemKCT0000804Seoul National University Bundang Hospital290
招募中
不适用
Anticoagulation therapy around catheter ablation for atrial fibrillation -Dabigatran vs. WarfarinAtrial fibrillationJPRN-UMIN000006907DAWN-AF-Trial Society100
招募中
1 期
The effect of coagulation factors on the reduction of joint/ non-joint bleeding and the consumption of coagulation factor in patients with severe A hemophiliaHemophilia.Hereditary factor VIII deficiencyIRCT20170211032495N1Vice chancellor for research of Tehran University of Medical Sciences15
进行中（未招募）
1 期
Anticoagulant Regimens Given to achieve thrombus regression and reduce clinical Outcomes among patients with Non device-related intra-cardiac thrombus: a randomized Assessment Under direct oral anticoagulant and vitamin K antagonist Therapy – the ARGONAUT trialintra-cardiac thrombusMedDRA version: 20.0Level: PTClassification code: 10048620Term: Intracardiac thrombus Class: 100000004849CTIS2024-512685-33-00Centre Hospitalier Universitaire De Nimes340
已完成
不适用
Controlled Anti-platelet medical therapy based on rapid CYP2C19 gene evaluation in Acute myocardial infarctioAcute myocardial infarctionJPRN-UMIN000008151Graduate School of Medical Sciences, Kumamoto University100